MAIA vs MTD · $56.9M cap vs P/E 27, rev $1.97B
MAIA Biotechnology Inc. (MAIA) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
MAIA Biotechnology Inc. (MAIA) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported MAIA revenue for 2024-12-31 was $0. Net income was -$23.3M. MAIA currently screens at market cap $56.9M.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
MAIA currently screens at market cap $56.9M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the MAIA and MTD stock pages for the full models.
Not investment advice.